221800 — U2Bio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for U2Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,837	4,512	16,485	36,921	36,792
Net Total Accounts Receivable
Net Total Receivables	14,732	16,708	21,759	10,183	7,391
Total Inventory
Prepaid Expenses
Total Current Assets	18,987	21,580	38,869	47,873	45,172
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,107	1,119	1,177	1,871	1,549
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	21,977	22,997	41,334	51,028	49,199
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7,182	14,437	17,734	14,634	8,003
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	14,641	17,056	19,811	17,184	11,208
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	7,335	5,942	21,524	33,844	37,991
Total Liabilities & Shareholders' Equity	21,977	22,997	41,334	51,028	49,199
Total Common Shares Outstanding